(TSX-V:TTI),(Other OTC:TTIPF), SAN DIEGO, Dec. 09, 2025 (GLOBE NEWSWIRE) — Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) (“Thiogenesis” or the “Company”), a clinical-stage biotechnology company developing next-generation sulfur-based prodrugs for rare mitochondrial and metabolic diseases, today announced that Brook Riggins, CFO and director, will present live at Life Sciences Virtual Investor Forum hosted by VirtualInvestorConferences.com, […]

(NYSE:CDP), SAN FRANCISCO, Dec. 09, 2025 (GLOBE NEWSWIRE) — Advisor Access spoke at length with Stephen E. Budorick, president and CEO. Advisor Access: What sets COPT Defense apart from other REITs? Stephen Budorick: COPT Defense's business model focuses on owning properties and developable land (Defense/IT Properties) near key United States defense installations whose missions have

(Other OTC:PGABF),(Nasdaq First North Sweden:PROGEN),(Nasdaq First North Sweden:PROGEN.ST),(Other OTC:DTCFF),(CNSX:DTC),(CNSX:DTC.CN),(Other OTC:ECHQF),(AUST:EIQ),(AUST:EIQ.AX),(Other OTC:TTIPF),(TSX-V:TTI),(Other OTC:GNVR),(NASDAQ:INM),(Other OTC:BICX),(Other OTC:INNMF),(AUST:ATX.AX), NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) — Virtual Investor Conferences, the leading proprietary investor conference series, announced the agenda for the Life Sciences Virtual Investor Forum to be held December 11th. Individual investors, institutional investors, advisors, and analysts are invited

Thiogenesis Therapeutics, Corp. to Present at the Life Sciences Virtual Investor Forum December 11th Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com GlobeNewswire December 09, 2025 SAN DIEGO, Dec. 09, 2025 (GLOBE NEWSWIRE) — Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) (“Thiogenesis” or the “Company”), a

COPT Defense Properties (NYSE: CDP), President & CEO Steve Budorick Interviewed by Advisor Access COPT Defense Properties: A Unique Specialty Real Estate Franchise Supporting National Defense GlobeNewswire December 09, 2025 SAN FRANCISCO, Dec. 09, 2025 (GLOBE NEWSWIRE) — Advisor Access spoke at length with Stephen E. Budorick, president and CEO. Advisor Access: What sets COPT

Life Sciences Virtual Investor Forum Agenda Announced for December 11th Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com GlobeNewswire December 09, 2025 NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) — Virtual Investor Conferences, the leading proprietary investor conference series, announced the agenda for the Life Sciences Virtual Investor Forum to be held December

America's Joy Magnet, Shari Alyse, leads a team of 24 co-authors writing about keeping the spark of joy alive even in difficult circumstances. Brave Healer Productions announces the release of Joy Unleashed: The Ultimate Guide to Living Your Best Life. Available in print and eBook, the new book helmed by lead author and media personality

Amid concerns about the economy and a potential market crash, 93% of 2026 buyers and sellers plan to change their habits to save money in the year ahead. 40% of Americans planning to buy or sell a home in 2026 worry about a potential real estate market crash, while nearly all (98%) expect challenges when

Tidal Metals and Alexander Chemical Corporation have signed a Memorandum of Understanding for marketing, packaging, and distributing chlorine, a valuable co-product produced as part of Tidal Metals' revolutionary magnesium-from-seawater process. Over 90% of primary magnesium metal is produced by China using an 80-year-old, environmentally damaging, and energy-intensive refining process for mined magnesium ores. The US

MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can distinguish single-base mismatches across all sgRNA positions with near-zero off-target activity. By selectively removing wild-type DNA before sequencing, it boosts true mutant signals up to tens of times and enables detection as low as ~0.005% VAF. The technique improves